Ronaghi Mostafa 4
4 · Summit Therapeutics Inc. · Filed Apr 15, 2024
Insider Transaction Report
Form 4
Ronaghi Mostafa
Director
Transactions
- Award
Stock Option (right to buy)
2024-04-11+200,000→ 200,000 totalExercise: $4.03Exp: 2034-04-11→ Common Stock (200,000 underlying) - Award
Stock Option (right to buy)
2024-04-11+25,315→ 225,315 totalExercise: $4.03Exp: 2034-04-11→ Common Stock (25,315 underlying)
Footnotes (3)
- [F1]The option was granted on April 11, 2024. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on April 11, 2025, subject to the director remaining as a non-salaried director on each such vesting date.
- [F2]Not applicable.
- [F3]The option was granted on April 11, 2024 and represents a pro rata amount of the annual 35,000 option board grant based approximately on the number of days the reporting person is anticipated to serve as a director in 2024. The shares underlying the option are scheduled to vest in full on December 31, 2024, subject to the director remaining as a non-salaried director on such vesting date.